<?xml version='1.0' encoding='utf-8'?>
<document id="25465944"><sentence text="Pharmacokinetic interaction of finasteride with tamsulosin hydrochloride: an open-label, randomized, 3-period crossover study in healthy Chinese male volunteers."><entity charOffset="31-42" id="DDI-PubMed.25465944.s1.e0" text="finasteride" /><entity charOffset="48-72" id="DDI-PubMed.25465944.s1.e1" text="tamsulosin hydrochloride" /><pair ddi="false" e1="DDI-PubMed.25465944.s1.e0" e2="DDI-PubMed.25465944.s1.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s1.e0" e2="DDI-PubMed.25465944.s1.e1" /></sentence><sentence text="The primary aim of this study was to evaluate whether there was clinically significant pharmacokinetic (PK) interaction between finasteride and tamsulosin in healthy Chinese male subjects"><entity charOffset="128-139" id="DDI-PubMed.25465944.s2.e0" text="finasteride" /><entity charOffset="144-154" id="DDI-PubMed.25465944.s2.e1" text="tamsulosin" /><pair ddi="false" e1="DDI-PubMed.25465944.s2.e0" e2="DDI-PubMed.25465944.s2.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s2.e0" e2="DDI-PubMed.25465944.s2.e1" /></sentence><sentence text="" /><sentence text="This was an open-label, randomized, 3-period, crossover study" /><sentence text=" Subjects received single and multiple doses of 5 mg finasteride alone, single and multiple doses of 0"><entity charOffset="53-64" id="DDI-PubMed.25465944.s5.e0" text="finasteride" /></sentence><sentence text="2 mg tamsulosin hydrochloride sustained-release capsule alone, and single and multiple doses of 5 mg finasteride with 0"><entity charOffset="5-29" id="DDI-PubMed.25465944.s6.e0" text="tamsulosin hydrochloride" /><entity charOffset="101-112" id="DDI-PubMed.25465944.s6.e1" text="finasteride" /><pair ddi="false" e1="DDI-PubMed.25465944.s6.e0" e2="DDI-PubMed.25465944.s6.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s6.e0" e2="DDI-PubMed.25465944.s6.e1" /></sentence><sentence text="2 mg tamsulosin hydrochloride, in an order determined by a computerized randomization schedule"><entity charOffset="5-29" id="DDI-PubMed.25465944.s7.e0" text="tamsulosin hydrochloride" /></sentence><sentence text=" Blood samples were collected up to 48 hours after dosing on study day 1 and up to 24 hours after dosing on study day 9 for determination of plasma concentrations with a validated LC-MS/MS method" /><sentence text=" Pharmacokinetic parameters were estimated via noncompartmental methods" /><sentence text=" Tolerability was evaluated by monitoring adverse events, laboratory assays, vital signs, and 12-lead ECG" /><sentence text="" /><sentence text="Fifteen subjects were enrolled, and 14 completed the study" /><sentence text=" The geometric mean ratios (GMRs) (90% CIs) of AUC(τ,ss) and C(max,ss) values of finasteride at steady state between coadministration of finasteride and tamsulosin hydrochloride and finasteride alone were 1"><entity charOffset="137-148" id="DDI-PubMed.25465944.s13.e0" text="finasteride" /><entity charOffset="153-177" id="DDI-PubMed.25465944.s13.e1" text="tamsulosin hydrochloride" /><entity charOffset="182-193" id="DDI-PubMed.25465944.s13.e2" text="finasteride" /><pair ddi="false" e1="DDI-PubMed.25465944.s13.e0" e2="DDI-PubMed.25465944.s13.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s13.e0" e2="DDI-PubMed.25465944.s13.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s13.e0" e2="DDI-PubMed.25465944.s13.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s13.e1" e2="DDI-PubMed.25465944.s13.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s13.e1" e2="DDI-PubMed.25465944.s13.e2" /></sentence><sentence text="14 (1" /><sentence text="05-1" /><sentence text="23) and 1" /><sentence text="06 (0" /><sentence text="99-1" /><sentence text="14), respectively" /><sentence text=" The GMRs (90% CIs) for AUC(0-t) and C(max) values of finasteride for a single dose of coadministration of finasteride and tamsulosin hydrochloride and finasteride alone were 1"><entity charOffset="107-118" id="DDI-PubMed.25465944.s20.e0" text="finasteride" /><entity charOffset="123-147" id="DDI-PubMed.25465944.s20.e1" text="tamsulosin hydrochloride" /><entity charOffset="152-163" id="DDI-PubMed.25465944.s20.e2" text="finasteride" /><pair ddi="false" e1="DDI-PubMed.25465944.s20.e0" e2="DDI-PubMed.25465944.s20.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s20.e0" e2="DDI-PubMed.25465944.s20.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s20.e0" e2="DDI-PubMed.25465944.s20.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s20.e1" e2="DDI-PubMed.25465944.s20.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s20.e1" e2="DDI-PubMed.25465944.s20.e2" /></sentence><sentence text="02 (0" /><sentence text="94-1" /><sentence text="11) and 1" /><sentence text="06 (1" /><sentence text="01-1" /><sentence text="11), respectively" /><sentence text=" The GMRs (90% CIs) for AUC(τ,ss) and C(max,ss) values of tamsulosin at steady-state for coadministration of finasteride and tamsulosin hydrochloride and tamsulosin hydrochloride alone were 1"><entity charOffset="58-68" id="DDI-PubMed.25465944.s27.e0" text="tamsulosin" /><entity charOffset="109-120" id="DDI-PubMed.25465944.s27.e1" text="finasteride" /><entity charOffset="125-149" id="DDI-PubMed.25465944.s27.e2" text="tamsulosin hydrochloride" /><entity charOffset="154-178" id="DDI-PubMed.25465944.s27.e3" text="tamsulosin hydrochloride" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e0" e2="DDI-PubMed.25465944.s27.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e0" e2="DDI-PubMed.25465944.s27.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e0" e2="DDI-PubMed.25465944.s27.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e0" e2="DDI-PubMed.25465944.s27.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e1" e2="DDI-PubMed.25465944.s27.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e1" e2="DDI-PubMed.25465944.s27.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e1" e2="DDI-PubMed.25465944.s27.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e2" e2="DDI-PubMed.25465944.s27.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s27.e2" e2="DDI-PubMed.25465944.s27.e3" /></sentence><sentence text="18 (1" /><sentence text="05-1" /><sentence text="33) and 1" /><sentence text="23 (1" /><sentence text="06-1" /><sentence text="43), respectively" /><sentence text=" The GMRs (90% CIs) for AUC(0-t) and C(max) values of tamsulosin for a single dose of coadministration of finasteride and tamsulosin hydrochloride and tamsulosin hydrochloride alone were 1"><entity charOffset="24-32" id="DDI-PubMed.25465944.s34.e0" text="AUC(0-t)" /><entity charOffset="54-64" id="DDI-PubMed.25465944.s34.e1" text="tamsulosin" /><entity charOffset="106-117" id="DDI-PubMed.25465944.s34.e2" text="finasteride" /><entity charOffset="122-146" id="DDI-PubMed.25465944.s34.e3" text="tamsulosin hydrochloride" /><entity charOffset="151-175" id="DDI-PubMed.25465944.s34.e4" text="tamsulosin hydrochloride" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e0" e2="DDI-PubMed.25465944.s34.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e0" e2="DDI-PubMed.25465944.s34.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e0" e2="DDI-PubMed.25465944.s34.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e0" e2="DDI-PubMed.25465944.s34.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e0" e2="DDI-PubMed.25465944.s34.e4" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e1" e2="DDI-PubMed.25465944.s34.e1" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e1" e2="DDI-PubMed.25465944.s34.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e1" e2="DDI-PubMed.25465944.s34.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e1" e2="DDI-PubMed.25465944.s34.e4" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e2" e2="DDI-PubMed.25465944.s34.e2" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e2" e2="DDI-PubMed.25465944.s34.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e2" e2="DDI-PubMed.25465944.s34.e4" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e3" e2="DDI-PubMed.25465944.s34.e3" /><pair ddi="false" e1="DDI-PubMed.25465944.s34.e3" e2="DDI-PubMed.25465944.s34.e4" /></sentence><sentence text="04 (0" /><sentence text="97-1" /><sentence text="10) and 1" /><sentence text="04 (0" /><sentence text="98-1" /><sentence text="11), respectively" /><sentence text=" Statistical analyses confirmed that the 90% CIs for these PK parameters were within the predefined not clinically significant PK drug-drug interaction effect boundaries (0" /><sentence text="5-2" /><sentence text="0) in this study" /><sentence text=" If comparing the findings with narrower boundaries (0" /><sentence text="8-1" /><sentence text="25), the conclusion may not be supportive for tamsulosin hydrochloride"><entity charOffset="46-70" id="DDI-PubMed.25465944.s46.e0" text="tamsulosin hydrochloride" /></sentence><sentence text=" During the study, a total of 4 adverse events were reported in 3 subjects including allergic reaction, abnormal findings on an ECG, a slight increase in alanine aminotransferase, and a positive result on glucose urine test"><entity charOffset="154-161" id="DDI-PubMed.25465944.s47.e0" text="alanine" /></sentence><sentence text="" /><sentence text="Both finasteride and tamsulosin hydrochloride were well tolerated"><entity charOffset="5-16" id="DDI-PubMed.25465944.s49.e0" text="finasteride" /><entity charOffset="21-45" id="DDI-PubMed.25465944.s49.e1" text="tamsulosin hydrochloride" /><pair ddi="false" e1="DDI-PubMed.25465944.s49.e0" e2="DDI-PubMed.25465944.s49.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s49.e0" e2="DDI-PubMed.25465944.s49.e1" /></sentence><sentence text=" Coadministration of finasteride and tamulosin hydrochloride seems unlikely to lead to a clinically significant PK drug-drug interaction, after a single dose and at steady state"><entity charOffset="21-32" id="DDI-PubMed.25465944.s50.e0" text="finasteride" /><entity charOffset="37-60" id="DDI-PubMed.25465944.s50.e1" text="tamulosin hydrochloride" /><pair ddi="false" e1="DDI-PubMed.25465944.s50.e0" e2="DDI-PubMed.25465944.s50.e0" /><pair ddi="false" e1="DDI-PubMed.25465944.s50.e0" e2="DDI-PubMed.25465944.s50.e1" /></sentence><sentence text="" /></document>